3-36993455-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000413740.2(MLH1):​c.-93G>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.244 in 1,283,016 control chromosomes in the GnomAD database, including 42,875 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★★).

Frequency

Genomes: 𝑓 0.23 ( 4663 hom., cov: 33)
Exomes 𝑓: 0.25 ( 38212 hom. )

Consequence

MLH1
ENST00000413740.2 5_prime_UTR

Scores

2

Clinical Significance

Benign reviewed by expert panel U:1B:12

Conservation

PhyloP100: -0.737

Publications

214 publications found
Variant links:
Genes affected
MLH1 (HGNC:7127): (mutL homolog 1) The protein encoded by this gene can heterodimerize with mismatch repair endonuclease PMS2 to form MutL alpha, part of the DNA mismatch repair system. When MutL alpha is bound by MutS beta and some accessory proteins, the PMS2 subunit of MutL alpha introduces a single-strand break near DNA mismatches, providing an entry point for exonuclease degradation. The encoded protein is also involved in DNA damage signaling and can heterodimerize with DNA mismatch repair protein MLH3 to form MutL gamma, which is involved in meiosis. This gene was identified as a locus frequently mutated in hereditary nonpolyposis colon cancer (HNPCC). [provided by RefSeq, Aug 2017]
MLH1 Gene-Disease associations (from GenCC):
  • Lynch syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, ClinGen, Orphanet
  • Lynch syndrome 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp
  • Muir-Torre syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Ambry Genetics, G2P, Orphanet
  • mismatch repair cancer syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), Orphanet, ClinGen
  • Lynch syndrome 1
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • ovarian cancer
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • malignant pancreatic neoplasm
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • rhabdomyosarcoma
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • prostate cancer
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • breast cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
  • hereditary breast carcinoma
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.75).
BP6
Variant 3-36993455-G-A is Benign according to our data. Variant chr3-36993455-G-A is described in ClinVar as Benign. ClinVar VariationId is 89600.Status of the report is reviewed_by_expert_panel, 3 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.538 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000413740.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MLH1
NM_000249.4
MANE Select
c.-93G>A
upstream_gene
N/ANP_000240.1
MLH1
NM_001354628.2
c.-93G>A
upstream_gene
N/ANP_001341557.1
MLH1
NM_001354629.2
c.-93G>A
upstream_gene
N/ANP_001341558.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MLH1
ENST00000413740.2
TSL:1
c.-93G>A
5_prime_UTR
Exon 1 of 15ENSP00000416476.2
MLH1
ENST00000673673.2
c.-93G>A
5_prime_UTR
Exon 1 of 18ENSP00000500979.2
MLH1
ENST00000536378.5
TSL:2
c.-725G>A
5_prime_UTR
Exon 1 of 18ENSP00000444286.2

Frequencies

GnomAD3 genomes
AF:
0.232
AC:
35278
AN:
152130
Hom.:
4667
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.172
Gnomad AMI
AF:
0.170
Gnomad AMR
AF:
0.274
Gnomad ASJ
AF:
0.328
Gnomad EAS
AF:
0.554
Gnomad SAS
AF:
0.384
Gnomad FIN
AF:
0.247
Gnomad MID
AF:
0.367
Gnomad NFE
AF:
0.215
Gnomad OTH
AF:
0.260
GnomAD4 exome
AF:
0.246
AC:
278381
AN:
1130768
Hom.:
38212
Cov.:
16
AF XY:
0.251
AC XY:
144931
AN XY:
577786
show subpopulations
African (AFR)
AF:
0.168
AC:
4557
AN:
27162
American (AMR)
AF:
0.329
AC:
14481
AN:
44030
Ashkenazi Jewish (ASJ)
AF:
0.330
AC:
7963
AN:
24094
East Asian (EAS)
AF:
0.545
AC:
20828
AN:
38216
South Asian (SAS)
AF:
0.374
AC:
29756
AN:
79520
European-Finnish (FIN)
AF:
0.253
AC:
13376
AN:
52930
Middle Eastern (MID)
AF:
0.349
AC:
1724
AN:
4946
European-Non Finnish (NFE)
AF:
0.213
AC:
172531
AN:
810386
Other (OTH)
AF:
0.266
AC:
13165
AN:
49484
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
11792
23583
35375
47166
58958
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5326
10652
15978
21304
26630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.232
AC:
35286
AN:
152248
Hom.:
4663
Cov.:
33
AF XY:
0.238
AC XY:
17732
AN XY:
74448
show subpopulations
African (AFR)
AF:
0.172
AC:
7146
AN:
41542
American (AMR)
AF:
0.274
AC:
4192
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.328
AC:
1140
AN:
3472
East Asian (EAS)
AF:
0.554
AC:
2871
AN:
5178
South Asian (SAS)
AF:
0.383
AC:
1850
AN:
4828
European-Finnish (FIN)
AF:
0.247
AC:
2620
AN:
10596
Middle Eastern (MID)
AF:
0.378
AC:
111
AN:
294
European-Non Finnish (NFE)
AF:
0.215
AC:
14649
AN:
68016
Other (OTH)
AF:
0.262
AC:
552
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1379
2758
4137
5516
6895
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
394
788
1182
1576
1970
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.231
Hom.:
18700
Bravo
AF:
0.234
Asia WGS
AF:
0.445
AC:
1546
AN:
3478

ClinVar

ClinVar submissions as Germline
Significance:Benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not specified (4)
-
1
1
Colorectal cancer, hereditary nonpolyposis, type 2 (2)
-
-
2
Lynch syndrome (2)
-
-
2
not provided (2)
-
-
1
Hereditary cancer-predisposing syndrome (1)
-
-
1
Hereditary nonpolyposis colorectal neoplasms (1)
-
-
1
Muir-Torré syndrome;C1333991:Colorectal cancer, hereditary nonpolyposis, type 2;C5399763:Mismatch repair cancer syndrome 1 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.75
CADD
Benign
3.6
DANN
Benign
0.77
PhyloP100
-0.74
PromoterAI
0.016
Neutral
Mutation Taster
=300/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1800734; hg19: chr3-37034946; COSMIC: COSV99212309; API